Repare Therapeutics Inc is a biotechnology business based in the US. Repare Therapeutics shares (RPTX) are listed on the NASDAQ and all prices are listed in US Dollars. Repare Therapeutics employs 104 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Repare Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RPTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Repare Therapeutics stock price (NASDAQ: RPTX)Use our graph to track the performance of RPTX stocks over time.
Repare Therapeutics shares at a glance
|Latest market close||$32.32|
|52-week range||$21.45 - $46.44|
|50-day moving average||$32.81|
|200-day moving average||$33.26|
|Wall St. target price||$46.43|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.11|
Buy Repare Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Repare Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Repare Therapeutics price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-4.58%|
|3 months (2021-04-28)||-2.36%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Repare Therapeutics financials
|Gross profit TTM||$-37,750,000|
|Return on assets TTM||-18.8%|
|Return on equity TTM||-36.02%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
Shorting Repare Therapeutics shares
There are currently 709,628 Repare Therapeutics shares held short by investors – that's known as Repare Therapeutics's "short interest". This figure is 2.5% down from 728,111 last month.
There are a few different ways that this level of interest in shorting Repare Therapeutics shares can be evaluated.
Repare Therapeutics's "short interest ratio" (SIR)
Repare Therapeutics's "short interest ratio" (SIR) is the quantity of Repare Therapeutics shares currently shorted divided by the average quantity of Repare Therapeutics shares traded daily (recently around 173080). Repare Therapeutics's SIR currently stands at 4.1. In other words for every 100,000 Repare Therapeutics shares traded daily on the market, roughly 4100 shares are currently held short.
However Repare Therapeutics's short interest can also be evaluated against the total number of Repare Therapeutics shares, or, against the total number of tradable Repare Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Repare Therapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Repare Therapeutics shares in existence, roughly 20 shares are currently held short) or 0.0419% of the tradable shares (for every 100,000 tradable Repare Therapeutics shares, roughly 42 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Repare Therapeutics.
Find out more about how you can short Repare Therapeutics stock.
Repare Therapeutics share dividends
We're not expecting Repare Therapeutics to pay a dividend over the next 12 months.
Repare Therapeutics overview
Repare Therapeutics Inc. , a precision oncology company, discovers and develops novel therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small-molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, a proprietary drug discovery program for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montréal, Canada.
Stocks similar to Repare Therapeutics
Repare Therapeutics in the news
Were Hedge Funds Right About Repare Therapeutics Inc. (RPTX)?
How Much Are Repare Therapeutics Inc. (NASDAQ:RPTX) Insiders Taking Off The Table?
Repare Therapeutics files automatic mixed securities shelf
Frequently asked questionsWhat percentage of Repare Therapeutics is owned by insiders or institutions?
Currently 1.467% of Repare Therapeutics shares are held by insiders and 85.062% by institutions. How many people work for Repare Therapeutics?
Latest data suggests 104 work at Repare Therapeutics. When does the fiscal year end for Repare Therapeutics?
Repare Therapeutics's fiscal year ends in December. Where is Repare Therapeutics based?
Repare Therapeutics's address is: 7210 Frederick-Banting, Montreal, QC, Canada, H4S 2A1 What is Repare Therapeutics's ISIN number?
Repare Therapeutics's international securities identification number is: US7602731025
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert